Note 9 - Inventory |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory Disclosure [Text Block] |
9. Inventory
Inventory, net of reserves, at September 30, 2026 and March 31, 2026 consisted of the following (in thousands):
The Company recorded inventory write-downs of $1.2 million and $1.1 million for the three months ended September 30, 2026 and 2025, respectively. The Company recorded inventory write-downs of $2.3 million and $1.8 million for the six months ended September 30, 2026 and 2025, respectively. These write-downs were based on the Company's evaluation of its inventory on hand for excess quantities and obsolescence.
Deferred program costs as of September 30, 2026 and March 31, 2026 primarily represent costs incurred on programs where the Company needs to complete performance obligations before the related revenue and costs will be recognized.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||